BIOVERSYS AG
22Patents
22Active
22Granted
51Portfolio score
Filing activity: Jun 25, 2010 → Feb 7, 2024 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8912329B2 | Composition for treatment of tuberculosis | Chemistry; Metallurgy | 20 | Active |
| US10947237B2 | Antimicrobial compounds and methods of making and using the same | Chemistry; Metallurgy | 7 | Active |
| US9682079B2 | Composition for treatment of pathogens that are resistant to tetracyclines | Emerging Cross-Sectional Technologies | 1 | Active |
| US10934295B2 | Antimicrobials and methods of making and using same | Human Necessities | 1 | Active |
| US10815237B2 | Antimicrobials and methods of making and using same | Human Necessities | 1 | Active |
| US11098047B2 | Antimicrobials and methods of making and using same | Human Necessities | 1 | Active |
| US10815238B2 | Antimicrobial compounds and methods of making and using the same | Chemistry; Metallurgy | 1 | Active |
| US12370184B2 | Antibiotic combination therapies | Human Necessities | 0 | Active |
| US11207305B2 | Antibiotic combination therapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11903934B2 | Rifabutin treatment methods, uses, and compositions | Human Necessities | 0 | Active |
| US12234238B2 | Antimicrobial compounds and methods of making and using the same | Human Necessities | 0 | Active |
| US11351158B2 | Rifabutin treatment methods, uses, and compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US12257241B2 | Rifabutin treatment methods, uses, and compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US12152031B2 | Biodefense agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US11253499B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US12297201B2 | Substituted pyrrolo[2,3-d]pyrimidines as antimicrobials | Human Necessities | 0 | Active |
| US11999739B2 | Antimicrobials methods of making and using the same | Human Necessities | 0 | Active |
| US11833139B2 | Rifabutin treatment methods, uses, and compositions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11969423B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US11254689B2 | Compounds | Human Necessities | 0 | Active |
| US12403133B2 | Rifabutin treatment methods, uses, and compositions | Human Necessities | 0 | Active |
| US11344537B2 | Rifabutin treatment methods, uses, and compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.